Treatment outcome of tofacitinib dose reduction to 5 mg twice daily (bid) vs remaining on 10 mg bid in patients with ulcerative colitis who were in stable remission on 10 mg bid: updated 30 month data from the double-blind, randomized riveting study
GASTROENTEROLOGY（2023）
关键词
ulcerative colitis,tofacitinib dose reduction,tu1735 treatment outcome,stable remission reduction,double-blind
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要